# OnCo record ifm (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ifm/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ifm" ;
  schema:name "Intergroupe Francophone du Myélome (IFM)"@en ;
  schema:alternateName "Intergroupe Francophone du Myelome"@en, "IFM"@en ;
  schema:description "The IFM is the French-speaking myeloma cooperative group created in 1994, with 140 French and 33 Belgian centres, whose trials set melphalan-autograft intensification, bortezomib induction and lenalidomide maintenance; in OnCo it leads CASSIOPEIA and IFM 2009."@en ;
  schema:url <https://onco.cc/companies/ifm/>, <https://www.myelome.fr> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://www.myelome.fr/l-ifm>, <https://clinicaltrials.gov/search?lead=Intergroupe%20Francophone%20du%20Myelome> ;
  onco:tag "ctgov-sponsor", "cooperative-group" ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-transplant-eligible/> ;
  onco:trials <https://onco.cc/trials/cassiopeia/>, <https://onco.cc/trials/ifm-2009/> .